PCR System Moves Ultra-Fast Testing From Lab to Patients at Point of Need
A next generation person-portable diagnostic device aims to move complex molecular biology testing out of highly skilled laboratories to non-laboratory settings where they can be used quickly at the point of need. More...21 Jun 2022
First FDA-Authorized COVID-19 Test Identifies Specific SARS-CoV-2 Lineages
The US FDA has authorized the first test for the identification and differentiation of SARS-CoV-2 Phylogenetic Assignment of Named Global Outbreak (PANGO) lineages, which are genetic variations in circulating virus strains. More...20 Jun 2022
LumiraDx CE Marked COVID/Influenza Molecular Tests to Expand Global Testing Capabilities
LumiraDx (London, UK) has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete. These high-sensitivity and high-throughput tests help to expand testing capabilities across the globe. More...09 Jun 2022
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Thermal Cycler
Axygen MaxyGene II
New
FLU/RSV Test
Humasis FLU/RSV Combo
In Other News
MIS-C Linked to Rare, Immune-Related Variants
Nasopharyngeal Swabs More Effective Than Saliva Tests at Detecting COVID-19
Blood Test Detects and Monitors Cell Death to Predict Disease Severity
World-First Method for Rapid Isolation and Characterization of COVID-19 Variants
Viral Antigen Detected in Cerebrospinal Fluid of COVID Patients
BD Launches Combination Test for COVID-19 and Influenza A/B
Seegene Unveils "$12 PCR Testing" Global Initiative to Help End COVID-19 Pandemic
LumiraDx Five-Minute SARS-CoV-2 Ag Ultra Test Aids Fast Clinical Decision-Making at POC
Cepheid’s `Plus` Version of COVID-19 Test Adds Third Gene Target for Detection of Future SARS-CoV-2 Variants
First-of-Its-Kind Saliva-Based Rapid Test Uses DNA Aptamer to Detect COVID-19
Swab with Unique Head Design Enables Accurate, More Reliable COVID-19 Test Results
Rapid Antigen COVID-19 Tests Not Keeping Pace with Variants of Concern
Next Generation COVID-19 Antigen Test to Offer Even Greater Sensitivity
Automated Nasal Swab Technology Creates Hands-Free Diagnostics Workflow
SARS-CoV-2 RT-PCR Test Uses Three-in-One Media Pooling Strategy to Increase Testing Throughput
Rapid Extraction-Less COVID-19 Diagnostic Assay Detects SARS-CoV-2 in 30 Minutes
Cytokine Signature Identifies COVID-19 Patients With Worst Prognosis
Blood Test Differentiates Severe COVID-19 from Preeclampsia in Pregnant Women
Novel Platform Detects Coronavirus Particles with “Slow Light”
COVID-19 Antibody Measurement Technology Assesses Virus Blocking Efficacy
Nucleic Acid Amplification Test Detects COVID-19 Without Using Instrument or Electricity
POC COVID-19 Test Detects and Differentiates SARS-CoV-2 Alpha Variant from Earlier Strains
First FDA Approved COVID-19 Breath Test Provides Results in Three Minutes
